Description
Read the Case 5.2 – Drug Dilemmas and fully answer the 6 questions (Uploaded Below)
Please use this strategy when you analyze a case:
- Identify and write the main issues found discussed in the case (who, what, how, where and when (the critical facts in a case).
- List all indicators (including stated "problems") that something is not as expected or as desired.
- Briefly analyze the issue with theories found in your textbook or other academic materials. Decide which ideas, models, and theories seem useful. Apply these conceptual tools to the situation. As new information is revealed, cycle back to sub steps a and b.
- Identify the areas that need improvement (use theories from your textbook) (Uploaded)
- Specify and prioritize the criteria used to choose action alternatives.
- Discover or invent feasible action alternatives.
- Examine the probable consequences of action alternatives.
- Select a course of action.
- Design and implementation plan/schedule.
- Create a plan for assessing the action to be implemented.
- Conclusion (every paper should end with a strong conclusion or summary)
Instructions:
- Need minimum 1000 words (Abstract, Analysis of Questions and Conclusion)
- Need 3 Peer reviewed References
- No Plagiarism Please

Explanation & Answer

This is the final woerk. Pleas check it. Thank you.
Running head: DRUG DILLEMAS
1
Drug Dilemmas
Student’s Name
Institutional Affiliation
DRUG DILEMMAS
2
Drug Dilemmas
Abstract
Just like the citizens, corporations too have rights. Such rights and responsibilities related
to their actions, especially when dealing with individuals. Pharmaceutical companies are no
different. They owe individual cities right in terms of ensuring their products are practical, costeffective, and do not result in any foreseeable harm. Pharmaceutical companies have to deal with
various moral obligations while also trying to remain profitable. These are explored into more
details in the essay below.
Analysis of Questions
1)
The United States spends more on prescriptions drugs in comparison with other
developed and developing countries. The high cost of prescription drugs is due to several factors.
First, the FDA has imposed stringent regulations regarding drug trials, and hence the higher cost.
Also, innovation is not as high as we are led to believe, while manufacturers find it hard to get a
license. Additionally, the pharmaceutical industry has a slow growth rate, which necessarily
leads to limited competition (Shaw, 2017). Overcome these problems requires that the FDA
improves its mode of approving and reviewing drug trials and testing. The price of drugs in the
United States is also not indicative of a competitive and fair market. It is because pharmaceutical
companies have a monopoly over the manufacture of drugs, further hurting the consumers.
Lack of value controls means that it becomes hard to regulate the cost of certain
medications. The patent life expectancy is also another hindrance. On average patents in the
United States lasts longer in comparison with the other developed nations (Shaw, 2016).
Therefore, manufacturers tend to be highly selective, and in the process, business rivalry with the
DRUG DILEMMAS
3
other manufactures is quite intense. Lack of stiff competition also means that the cost of drugs
remains relatively high. In case a manufacturer sees that a specific drug have a narrow margin,
they can stop manufacturing them without its recourse.
A limited market for certain drugs implies that manufacture...
